Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial

OBJECTIVE: Paclitaxel (P) is a standard second-line chemotherapy in the treatment of advanced gastric cancer. This study compared the clinical outcome of a paclitaxel plus raltitrexed (RP) regimen as second-line treatment in metastatic gastric cancer (MGC) patients. METHODS: An open, randomized, mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xiaoying, Chen, Zhiyu, Zhang, Xiaowei, Zhu, Xiaodong, Zhang, Wen, Qiu, Lixin, Wang, Chenchen, Huang, Mingzhu, Zhang, Zhe, Li, Wenhua, Yang, Lei, Guo, Weijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546090/
https://www.ncbi.nlm.nih.gov/pubmed/37653589
http://dx.doi.org/10.20892/j.issn.2095-3941.2023.0112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546090/
https://www.ncbi.nlm.nih.gov/pubmed/37653589
http://dx.doi.org/10.20892/j.issn.2095-3941.2023.0112

Ejemplares similares